In the latest quarter, 4 analysts provided ratings for Precision BioSciences (NASDAQ:DTIL), showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 0 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $49.75, along with a high estimate of $60.00 and a low estimate of $19.00. Observing a 1558.33% increase, the current average has risen from the previous average price target of $3.00.
Deciphering Analyst Ratings: An In-Depth Analysis
The standing of Precision BioSciences among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Patrick Trucchio | HC Wainwright & Co. | Maintains | Buy | $60.00 | – |
| Debjit Chattopadhyay | Guggenheim | Announces | Buy | $19.00 | – |
| Patrick Trucchio | HC Wainwright & Co. | Maintains | Buy | $60.00 | – |
| Patrick Trucchio | HC Wainwright & Co. | Adjusts | Buy | $60.00 | $3.00 |
Key Insights:
Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they ‘Maintain’, ‘Raise’ or ‘Lower’ their stance, it reflects their response to recent developments related to Precision BioSciences. This information provides a snapshot of how analysts perceive the current state of the company.
Rating: Offering insights into predictions, analysts assign qualitative values, from ‘Outperform’ to ‘Underperform’. These ratings convey expectations for the relative performance of Precision BioSciences compared to the broader market.
Price Targets: Analysts predict movements in price targets, offering estimates for Precision BioSciences’s future value. Examining the current and prior targets offers insights into analysts’ evolving expectations.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Precision BioSciences’s market…
Click Here to Read the Full Original Article at Cryptocurrencies Feed…
